Canada’s beer and cannabis industries represent two of the most heavily regulated sectors in the country, yet they operate under completely different excise tax regimes.
While the nation’s three largest brewers based on annual domestic sales—Molson Coors, Labatt, and Sleeman—benefit from a stable, volume-based tax that promotes predictability, Canada’s top three cannabis producers—Tilray Brands, Organigram Holdings, and Cronos Group—are hindered by a rigid, price-based floor that effectively taxes revenue rather than profit.
The excise tax burden demonstrates a major difference between the two industries. For the three largest brewers, annual excise duties range from approximately $27 million to $210 million, effectively consuming 14% to 16% of gross domestic sales.
Canada’s top cannabis producers, on the other hand, face significantly steeper taxes: Tilray Brands recently incurred excise duties of $90 million to $100 million (33% to 35%), Organigram Holdings paid $125 million to $135 million (38% to 40%), and Cronos Group faced the highest burden at $65 million to $75 million, which represents 58% to 61% of their gross branded sales.
While the big three brewers generated over 3.5 times the domestic sales of the big three cannabis producers in their most recent fiscal reports, they paid only 1.3 times the amount of excise tax.
The current federal framework charges a flat excise floor of $1 per gram (or 10% of the value, whichever is higher). This model was predicated on an assumed valuation of $10 per gram wholesale—a price point that never emerged. Because this floor does not adjust for the significant price compression seen since legalization, cannabis producers are left paying taxes based on phantom valuations.
For companies like Tilray, Organigram, and Cronos, effective domestic tax rates frequently range from 33% to over 60%. In recent periods, Cronos has seen effective rates climb as high as 58% to 61%. For retail sales, this means about 25-40% of the retail price of cannabis products paid by consumers is attributed to the excise tax.
Meanwhile, the brewing industry’s fiscal stability is rooted in a tax model based on liquid volume. Canada applies a flat federal rate of $37.69 per hectolitre on beer. Because this duty is based on volume instead of the retail price of the product, brewers maintain a predictable effective excise rate of approximately 14% to 16% of their wholesale sales, and about 6-7% of the retail cost for consumers.
So if a Canadian buys a 2-4 of beer for about $50, only about $3 of that is due to excise. If that same Canadian buys an ounce of cannabis for about $100, $28 of that price is due to the excise tax, with one dollar paid for each of the 28 grams.
In addition, the federal government shields these beer companies from price volatility by capping the automatic annual inflation adjustment on excise duties at 2%. Even for industrial giants that generate between $900 million and $1.5 billion in domestic sales, this structure ensures the tax burden remains consistent.
Unlike brewers, who can manage their costs to maintain margins, cannabis producers are essentially locked into a revenue-based tax that does not scale with production volume or market conditions.
The administrative burden further differentiates the two industries. Brewers operate with simpler processes that benefit from long-standing retail channels and clear regulatory relief, including sliding-scale tax reductions for smaller output tiers. Cannabis producers, conversely, must navigate often costly and challenging processes of ordering province-specific excise stamps, adding significant administrative overhead that is largely absent in the alcohol sector.
This isn’t an attack on Canada’s beer brewers. It’s an example of the challenges Canada’s cannabis industry faces. The current cannabis excise tax is a tax on gross revenue, not on the product’s value. Until the federal government admits this error and moves toward a percentage-based model or implements graduated relief similar to that found in the alcohol industry, the tax gap between Canada’s beer giants and cannabis producers will remain a defining feature of the country’s economic landscape.
For many cannabis producers, the only viable escape from this tax trap has been to aggressively focus on international medical exports, which remain entirely exempt from Canadian excise duties.